Status:
COMPLETED
Fat Cell Size in Insulin Resistance
Lead Sponsor:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions:
Obesity
Eligibility:
All Genders
18-65 years
Brief Summary
This study, conducted at Stanford University in Palo Alto, California, will examine how insulin metabolism and cardiovascular risk are altered in response to weight loss. Insulin is a natural hormone ...
Detailed Description
Little is known about the turnover of adipose cells in the fat depots of normal animals and human subjects. However, microarray analysis of adipose cell gene expression in high risk insulin-resistant ...
Eligibility Criteria
Inclusion
- INCLUSION AND EXCLUSION CRITERIA:
- Without regard to gender, race, or socioeconomic status, all subjects will be adult men and women. The racial/ethnic composition of the study population will be reflective of the communities surrounding Stanford University. Subjects will be recruited through placement of advertisements in local newspapers, but no subjects will be seen at NIH.
Exclusion
Key Trial Info
Start Date :
September 4 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2020
Estimated Enrollment :
782 Patients enrolled
Trial Details
Trial ID
NCT00341406
Start Date
September 4 2003
End Date
August 10 2020
Last Update
August 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), 9000
Bethesda, Maryland, United States, 20892